Precision BioSciences, Inc. Common Stock
Symbol: DTIL (NASDAQ)
6.86
▼ (-1.80%) -0.126
Company Description:
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Key Stats
- Today's Open: $7.04
- Today's High: $7.234
- Today's Low: $6.795
- Today's Volume: 182.81K
- Yesterday Close: $6.99
- Yesterday High: $7.2897
- Yesterday Low: $6.91
- Yesterday Volume: 145.45K
- Last Min Volume: 0
- Last Min High: $6.864
- Last Min Low: $6.857
- Last Min VWAP: $0
Company Profile
- Name: Precision BioSciences, Inc. Common Stock
- Website: https://www.precisionbiosciences.com
- Listed Date: 2019-03-28
- Location: DURHAM, NC
- Market Status: Active
- CIK Number: 0001357874
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $82.39M
- Round Lot: 100
- Outstanding Shares: 11.79M
- Asset Type: CS
RECENT FILINGS FOR DTIL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-30 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-09-02 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-08-06 | 8-K | View |
| 2025-07-08 | 4 | View |
| 2025-07-03 | 144 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
Latest News on DTIL